Pharmacy
Novartis announces FDA approval of Gilenya
Novartis announced that the U.S. Food and Drug Administration (FDA) has approved Gilenya (fingolimod) for the treatment of children and adolescents 10 to less than 18 years of age with relapsing forms of multiple sclerosis, making it the first disease-modifying therapy indicated for these patients.
NACDS issues memo to chain members on administration’s drug pricing policies
NACDS today sent the following memo to chain members: We are writing to update you on President Trump’s announcement today regarding prescription drug pricing policies, and anticipated future events related to it.
Retailers praise Trump for taking on drug prices
CVS Health and Walgreens have commended President Trump for vowing in a speech today to fight high drug prices.
Metro completes Coutu acquisition
Metro Inc. has completed its $4.5 billion ($3.6 billion U.S.) acquisition of the Jean Coutu Group, creating a food and drug retailer with more than 1,300 stores in Quebec, Ontario and New Brunswick.
PANTHERx selected by Otsuka to distribute Jynarque
PANTHERx Specialty Pharmacy has been selected by Otsuka America Pharmaceutical, Inc. to distribute Jynarque (tolvaptan), the only FDA-approved therapy for patients diagnosed with autosomal dominant polycystic kidney disease (ADPKD).
Express Scripts shows SafeGuardRx program offering better care at lower cost
Express Scripts released new data today showing significantly improved clinical outcomes and lower drug spending for patients with complex, high-cost conditions who are enrolled in a suite of technology-supported, value-based SafeGuardRx programs.
Sentara RMH Medical Center partners with Omnicell to enhance efficiency
Omnicell announced that Sentara RMH Medical Center, part of Sentara Healthcare in Virginia and northeastern North Carolina, has chosen to enhance control, efficiency and safety of its medication management processes with Omnicell’s newest central pharmacy automation, part of the company’s industry-
Diplomat Pharmacy names Griffin CEO
Diplomat Pharmacy Inc. announced that its board of directors has appointed Brian Griffin, executive vice president and chief executive officer of IngenioRx, the pharmacy benefit manager (PBM) of Anthem, as chief executive officer and chairman of the board of directors, effective June 4.
2018 Asembia Pharmacy Summit draws record crowds
The Asembia 2018 Specialty Pharmacy Summit set a new attendance record with over 6,500 attendees last week at the Wynn and Encore here. This is the thirteenth consecutive attendance record set by Asembia, reflecting the growth in specialty pharmacy.
NACDS praises Tennessee e-prescribing Law
The National Association of Chain Drug Stores (NACDS) is recognizing the leadership of Tennessee state legislators and Governor Bill Haslam (R) for the enactment of House Bill 1993, which requires that on or after January 1, 2020, prescriptions for Schedule II controlled substances in the state of T
NACDS-backed e-prescribing bill to fight opioid abuse passes
ARLINGTON, Va. – Legislation backed by the National Association of Chain Drug Stores (NACDS) to help address the opioid abuse epidemic was passed today by the House of Representatives Energy and Commerce Committee. The bill – the Every Prescription Conveyed Securely Act (H.R.
PhRMA launches Medicare ad campaign for seniors
Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) launched the “Let’s Talk About Medicare” advertising campaign focused on solutions to improve affordability and predictability for seniors in Medicare Part D.
PCMA: ADA report confirms drugmakers set to raise insulin prices
The Pharmaceutical Care Management Association (PCMA) released the following statement regarding a white paper released today by the American Diabetes Association on insulin prices: “The American Diabetes Association’s new white paper on insulin prices confirms that drugmakers set, and continue to r